Valion Bio, Inc. (VBIO) Shareholders’ equity 2021–2024
Valion Bio, Inc. (VBIO) shareholders’ equity at each fiscal year-end, per SEC filings.
$2.5MFY2024 · since FY2021: $13.3M → $2.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $2.5M | -29.2% |
| FY2023 | $3.6M | -1.4% |
| FY2022 | $3.6M | -72.6% |
| FY2021 | $13.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice